Cargando…
Retraction Note: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
Autores principales: | Dong, Huaying, Wang, Wei, Mo, Shaowei, Chen, Ru, Zou, Kejian, Han, Jing, Zhang, Fan, Hu, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832604/ https://www.ncbi.nlm.nih.gov/pubmed/36631904 http://dx.doi.org/10.1186/s13046-023-02596-2 |
Ejemplares similares
-
SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
por: Dong, Huaying, et al.
Publicado: (2018) -
Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022) -
Retraction: The absence of MyD88 has no effect on the induction of alternatively activated macrophage during Fasciola hepatica infection
por: Luo, HongLin, et al.
Publicado: (2012) -
EIF4A3 stabilizes the expression of lncRNA AGAP2‐AS1 to activate cancer‐associated fibroblasts via MyD88/NF‐κb signaling
por: Xu, Qingqing, et al.
Publicado: (2022) -
Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)